Bhaskar Chaudhuri, Ph.D.
With over 20 years of industry management experience, Dr. Chaudhuri brings extensive product development and commercialization knowledge to Corium. Dr. Chaudhuri served as President of Valeant Pharmaceuticals International from 2009 to 2010. Prior to Valeant Dr. Chaudhuri served as Chief Executive Officer and President of Dow Pharmaceutical Sciences, Inc. for seven years. Before joining Dow, he served as Vice President of R&D at Penederm, Inc., as General Manager of the Dermatology Division of Mylan Laboratories, and as Executive Vice President of Scientific Affairs at Bertek Pharmaceuticals, a subsidiary of Mylan, where he was responsible for research and development activities as well as certain of the company’s manufacturing operations.
As Chief Executive Officer of Dow, Dr. Chaudhuri led the company through a transition from a contract development focus to developing an attractive internal product pipeline and the company’s eventual merger with Valeant. Dr. Chaudhuri holds a Doctorate in Physical Pharmacy, an M.S. in Industrial Pharmacy and a B.S. in Pharmacy.